Franklin Street Properties Q2 revenue dips, net loss widens amid strategic review
Reuters2026/07/28 20:32
Overview
U.S. office REIT's Q2 revenue declined slightly yr/yr, net loss widened
Company's leased portfolio fell to 67.4% as lease expirations outpaced new leases
Company sold Greenwood Plaza for $19.4 mln after quarter-end, using proceeds to repay debt
Outlook
Company says expanded strategic review aims to maximize shareholder value amid evolving market conditions
Franklin Street Properties expects office market stabilization may support leasing and asset values over time
Company maintains suspension of quarterly dividend, board to reassess policy on a quarterly basis
Result Drivers
STRATEGIC REVIEW - Co said it expanded and formally launched its strategic review process with external advisors to evaluate a range of potential transactions
LEASE EXPIRATIONS - Leased percentage of portfolio fell as lease expirations exceeded new leases during the quarter
COST REDUCTION - General and administrative expenses fell by $1.7 mln in the first half due to lower personnel costs
Company press release: ID:nBw8bSNT8a
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 Revenue |
|
$26.36 mln |
|
Q2 Net Loss |
|
$16.61 mln |
|
Q2 Loss Per Share |
|
$0.25 |
|
Q2 Real Estate Operating Expenses |
|
$10.006 mln |
|
Reuters Recommended Reads
July 27 - Kilroy Realty Q2 revenue falls on lower portfolio occupancy rates
July 28 - BXP Q2 profit beats expectations on higher occupancy, raises FY outlook
July 28 - WP Carey Q2 revenue beats estimates on higher leases; AFFO outlook raised
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin's Weirdest Trader Yet? Fly Brain Makes a Profit
Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street -- WSJ
NASDAQ TRADE HALT CONTINUES <MAMK.O> REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM